PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure
Publication
, Conference
Donahue, MP; Wofe, MJ; Jennings, JL; Pedersen, B; Hauser, ER; Marchuk, DA; Kraus, WE
Published in: CIRCULATION
October 26, 2004
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
October 26, 2004
Volume
110
Issue
17
Start / End Page
555 / 555
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
77th Scientific Meeting of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Donahue, M. P., Wofe, M. J., Jennings, J. L., Pedersen, B., Hauser, E. R., Marchuk, D. A., & Kraus, W. E. (2004). PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure. In CIRCULATION (Vol. 110, pp. 555–555). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Donahue, M. P., M. J. Wofe, J. L. Jennings, B. Pedersen, E. R. Hauser, D. A. Marchuk, and W. E. Kraus. “PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure.” In CIRCULATION, 110:555–555. LIPPINCOTT WILLIAMS & WILKINS, 2004.
Donahue MP, Wofe MJ, Jennings JL, Pedersen B, Hauser ER, Marchuk DA, et al. PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 555–555.
Donahue, M. P., et al. “PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure.” CIRCULATION, vol. 110, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2004, pp. 555–555.
Donahue MP, Wofe MJ, Jennings JL, Pedersen B, Hauser ER, Marchuk DA, Kraus WE. PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 555–555.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
October 26, 2004
Volume
110
Issue
17
Start / End Page
555 / 555
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
77th Scientific Meeting of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology